Lives that can be saved with proper early detection and warning
millions of fatalities...
billion
Costs that can be saved with proper early detection and warning
US Dollars in hospitalization costs in the US alone
existing solutions
don't cut it
Clinical parameters monitoring
Implantable devices
Non-invasive monitoring
- Following weight, blood pressure, etc. is not nearly sensitive enough for monitoring of lung congestion in heart failure patients
- There are no methods for determination of patient’s deterioration at very early stage. Results: prevention of the deterioration and hospitalization is dramatically less efficient hospitalization is impossible
- No clinical indication for implantation for majority of Heart Failure patients
- Very expensive device
- Not suitable for mass monitoring
- Traditional transthoracic impedance measurement is not sensitive enough to enable prediction
- Radar Technologies are not supported with enough clinical evidence about efficacy of technology
SOLUTION
Revolutionary non-invasive, early detection device
EDEMA GUARD MONITOR
Registering accurately the most minuscule changes in lung fluid content allowing life-saving pre-emptive treatment at a very early stage
seconds
Measurement time while brushing teeth in the morning
Our device provides immediate results that will be displayed on the device and sent to the cardiologist when a medication adjustment is required
ABOUT US
We are a group of scientists and business people who strive to make a life-changing impact on patients suffering from heart failure lung edema.
With over 15 years of research and development we now have the solution that can literally revolutionize millions of HF patients' lives by enabling them to self-monitor their lung edema state and detect small changes at an even earliest stage.
Relevant scientific interviews and articles
2016
Duke Clinical Research Institute interview with Prof. Michael Kleiner Shochat from CARDIOSET
2016
2016
New Israeli Development will save lives
Monitoring device for for better HF prediction outcomes measuring lung fluid
Derivation of baseline lung impedance in chronic heart failure patient
Method for Expedient Detection and Convenient Monitoring of Pleural Effusion
Novel method for the preclinical detection of acute heart failure
IMPEDANCE-Guided Pre-emptive Treatment in Chronic Heart Failure
Prediction of cardiogenic pulmonary edema onset by monitoring right lung impedance
clinical trials
prevention
of heart failure hospitalizations
Potentially saving millions of lives and billions in hospitalization costs
Contact Us.
CardioSet Medical
Noa Building, 2nd floor, 16 Bar Kochba Rd. Bnei Brak 5120149, ISRAEL
Tel. +972-73-7997876
Fax +972-72-7997870